← Open Payments lookup

MELADY GENEREUX: Open Payments

NPI 1437370913 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$390 in 7 payments from 5 companies in 2025. Trend: 2023 $72 · 2024 $107 · 2025 $390

Food & beverage: $390
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$250
Otsuka America Pharmaceutical, Inc.2$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$35
Teva Pharmaceuticals USA, Inc.1$27
E.R. Squibb & Sons, L.L.C.1$21

Products named: INGREZZA, CAPLYTA, REXULTI, UZEDY, ABILIFY MAINTENA, COBENFY.

Industry payments across MA — which companies pay providers there.